Show
Sort by
-
Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial
-
- Journal Article
- A1
- open access
Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer
-
WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer
-
Genomic features of lung-recurrent hormone-sensitive prostate cancer
-
- Journal Article
- A1
- open access
Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial
-
- Journal Article
- A1
- open access
Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials
-
- Journal Article
- A1
- open access
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial
-
Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review
-
- Conference Paper
- C3
- open access
Genomic features of lung-recurrent hormone sensitive prostate cancer
-
- Conference Paper
- C3
- open access
Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach